Sandbox: wdx causes: Difference between revisions
Jump to navigation
Jump to search
Line 199: | Line 199: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Leukoerythroblastosis | ! align="center" style="background:#DCDCDC;" |Leukoerythroblastosis | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 291: | Line 291: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Leukocyte adhesion deficiency | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 321: | Line 321: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Cryopyrin-associated periodic syndromes | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 411: | Line 411: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Adult Still's disease | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 441: | Line 441: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Kawasaki disease | ! align="center" style="background:#DCDCDC;" |Kawasaki disease | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 501: | Line 501: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Sarcoidosis | ! align="center" style="background:#DCDCDC;" |Sarcoidosis | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 561: | Line 561: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Sweet syndrome | ! align="center" style="background:#DCDCDC;" |Sweet syndrome | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 621: | Line 621: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="6" |Infection | ! rowspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
Line 712: | Line 712: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Viral infection | ! align="center" style="background:#DCDCDC;" |Viral infection | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 742: | Line 742: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Granulomatous infections | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 772: | Line 772: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Bronchiectasis | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 802: | Line 802: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="5" |Metabolic | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metabolic | ||
!Diabetic coma | ! align="center" style="background:#DCDCDC;" |Diabetic coma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 833: | Line 833: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Acidosis | ! align="center" style="background:#DCDCDC;" |Acidosis | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 863: | Line 863: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Thyroid strom | ! align="center" style="background:#DCDCDC;" |Thyroid strom | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 893: | Line 893: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Hypercortisolism | ! align="center" style="background:#DCDCDC;" |Hypercortisolism | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 923: | Line 923: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Seizures | ! align="center" style="background:#DCDCDC;" |Seizures | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,014: | Line 1,014: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! align="center" style="background:#DCDCDC;" |Myeloid growth factors | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,134: | Line 1,134: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Catecholamines (epinephrine) | ! align="center" style="background:#DCDCDC;" |Catecholamines (epinephrine) | ||
| align="center" style="background:#F5F5F5;" + |Stimulation of bone marrow myelopoiesis and/or egress into the circulation | | align="center" style="background:#F5F5F5;" + |Stimulation of bone marrow myelopoiesis and/or egress into the circulation | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,164: | Line 1,164: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!ATRA | ! align="center" style="background:#DCDCDC;" |ATRA | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,194: | Line 1,194: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! rowspan="10" |Other | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
Line 1,225: | Line 1,225: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
!Allergy | ! align="center" style="background:#DCDCDC;" |Allergy | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,315: | Line 1,315: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Cigarette smoking | ! align="center" style="background:#DCDCDC;" |Cigarette smoking | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,345: | Line 1,345: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Stress/ | ! align="center" style="background:#DCDCDC;" |Stress/exercise | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,435: | Line 1,435: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Platelet clumping | ! align="center" style="background:#DCDCDC;" |Platelet clumping | ||
| align="center" style="background:#F5F5F5;" + |Spurious | | align="center" style="background:#F5F5F5;" + |Spurious | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 1,465: | Line 1,465: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Mixed cryoglobulinemia | ! align="center" style="background:#DCDCDC;" |Mixed cryoglobulinemia | ||
| align="center" style="background:#F5F5F5;" + |Spurious | | align="center" style="background:#F5F5F5;" + |Spurious | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | |
Revision as of 19:20, 13 September 2018
Differentiating Leukocytosis from Other Diseases
- Leukocytosis is defined as an elevated white blood cell (WBC) count greater than 11,000 per mm3 (11.0 × 109 per L).
- The most common type of leukocytosis is neutrophilia.
- Neutrophilia can be defined as an increase in the absolute number of mature neutrophils to greater than 7,000 per mm3 [7.0 × 109 per L].
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||||
Lab Findings | |||||||||||||||||||||||||||||
Physiologic | increased bone marrow production | demargination of peripheral blood neutrophils | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other | CBC | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | ||||||||||||
autonomous | reactive | WBC | HB | Plt | |||||||||||||||||||||||||
Hematologic | Hereditary neutrophilia | ||||||||||||||||||||||||||||
Hereditary chronic neutrophilia | |||||||||||||||||||||||||||||
Myeloproliferative neoplasms | |||||||||||||||||||||||||||||
Polycythemia Vera | |||||||||||||||||||||||||||||
Microangiopathic hemolytic anemia (MAHA) | |||||||||||||||||||||||||||||
Leukoerythroblastosis | |||||||||||||||||||||||||||||
Immature thrombocytopenia | |||||||||||||||||||||||||||||
Immunology/
Rheumatology |
Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Leukocyte adhesion deficiency | |||||||||||||||||||||||||||||
Cryopyrin-associated periodic syndromes | |||||||||||||||||||||||||||||
Rheumatoid arthritis | |||||||||||||||||||||||||||||
Juvenile onset rheumatoid arthritis | |||||||||||||||||||||||||||||
Adult Still's disease | |||||||||||||||||||||||||||||
Kawasaki disease | |||||||||||||||||||||||||||||
IBD | |||||||||||||||||||||||||||||
Sarcoidosis | |||||||||||||||||||||||||||||
Chronic hepatitis | |||||||||||||||||||||||||||||
Sweet syndrome | |||||||||||||||||||||||||||||
Acute Gout | |||||||||||||||||||||||||||||
Infection | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Acute bacterial | toxic granulations, Döhle bodies, and cytoplasmic vacuoles in neutrophils | ||||||||||||||||||||||||||||
Chronic | |||||||||||||||||||||||||||||
Viral infection | |||||||||||||||||||||||||||||
Granulomatous infections | |||||||||||||||||||||||||||||
Bronchiectasis | |||||||||||||||||||||||||||||
Metabolic | Diabetic coma | ||||||||||||||||||||||||||||
Acidosis | |||||||||||||||||||||||||||||
Thyroid strom | |||||||||||||||||||||||||||||
Hypercortisolism | |||||||||||||||||||||||||||||
Seizures | |||||||||||||||||||||||||||||
Medication | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Steriod | Release of granulocytes from the bone marrow | ||||||||||||||||||||||||||||
Myeloid growth factors | |||||||||||||||||||||||||||||
Lithium | |||||||||||||||||||||||||||||
Beta agonists | |||||||||||||||||||||||||||||
Cytokines | |||||||||||||||||||||||||||||
Catecholamines (epinephrine) | Stimulation of bone marrow myelopoiesis and/or egress into the circulation | ||||||||||||||||||||||||||||
ATRA | |||||||||||||||||||||||||||||
Other | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Allergy | |||||||||||||||||||||||||||||
Post splenectomy | |||||||||||||||||||||||||||||
Down syndrome | |||||||||||||||||||||||||||||
Cigarette smoking | |||||||||||||||||||||||||||||
Stress/exercise | |||||||||||||||||||||||||||||
Infancy | |||||||||||||||||||||||||||||
Pregnancy | |||||||||||||||||||||||||||||
Platelet clumping | Spurious | ||||||||||||||||||||||||||||
Mixed cryoglobulinemia | Spurious | ||||||||||||||||||||||||||||
Category | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint redness | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |